Vasodilation in human subcutaneous arteries induced by neuropeptide Y is mediated by neuropeptide Y Y1 receptors and is nitric oxide dependent
- 1 March 2000
- journal article
- Published by Canadian Science Publishing in Canadian Journal of Physiology and Pharmacology
- Vol. 78 (3) , 251-255
- https://doi.org/10.1139/y99-148
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- In vivo receptor characterization of neuropeptide Y‐induced effects in consecutive vascular sections of cat skeletal muscleBritish Journal of Pharmacology, 1997
- Neuropeptide Y potentiates noradrenaline-induced contraction through the neuropeptide Y Y1 receptorEuropean Journal of Pharmacology, 1996
- Apparent affinity and potency of BIBP3226, a non-peptide neuropeptide Y receptor antagonist, on purported neuropeptide Y Y1, Y2 and Y3 receptorsEuropean Journal of Pharmacology, 1995
- Neuropeptide Y stimulates proliferation of human vascular smooth muscle cells: cooperation with noradrenaline and ATPRegulatory Peptides, 1994
- Transient cerebral vasodilatory effect of neuropeptide y mediated by nitric oxideBrain Research Bulletin, 1993
- Cloned human neuropeptide Y receptor couples to two different second messenger systems.Proceedings of the National Academy of Sciences, 1992
- Effects of neuropeptide Y on the cardiovascular systemTrends in Pharmacological Sciences, 1987
- Innervation of human omental arteries and veins and vasomotor responses to noradrenaline, neuropeptide Y, substance P and vasoactive intestinal peptideRegulatory Peptides, 1985
- Neuropeptide Y potentiates the effect of various vasoconstrictor agents on rabbit blood vesselsBritish Journal of Pharmacology, 1984
- The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholineNature, 1980